Fibroblast Growth Factor 23 and Fetuin A are Independent Predictors for the Coronary Artery Disease Extent in Mild Chronic Kidney Disease

de Lusignan, 2005, Identifying patients with chronic kidney disease from general practice computer records, Fam Pract, 22, 234, 10.1093/fampra/cmi026

Parikh, 2008, Chronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study), Am J Cardiol, 102, 47, 10.1016/j.amjcard.2008.02.095

Weiner, 2004, Chronic kidney disease as a risk factor for cardiovascular disease and all cause mortality: A pooled analysis of community-based studies, J Am Soc Nephrol, 15, 1307, 10.1097/01.ASN.0000123691.46138.E2

Kramer, 2005, Association between chronic kidney disease and coronary artery calcification: The Dallas Heart Study, J Am Soc Nephrol, 16, 507, 10.1681/ASN.2004070610

Goodman, 2000, Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis, N Engl J Med, 342, 1478, 10.1056/NEJM200005183422003

Haydar, 2004, Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: A study comparing EBCT-generated coronary artery calcium scores and coronary angiography, Nephrol Dial Transplant, 19, 2307, 10.1093/ndt/gfh120

Noordzij, 2008, Mineral metabolism and mortality in dialysis patients: A reassessment of the K/DOQI guideline, Blood Purif, 26, 231, 10.1159/000118847

Kestenbaum, 2005, Serum phosphate levels and mortality risk among people with chronic kidney disease, J Am Soc Nephrol, 16, 520, 10.1681/ASN.2004070602

Block, 2004, Mineral metabolism, mortality and morbidity in maintenance hemodialysis, J Am Soc Nephrol, 15, 2208, 10.1097/01.ASN.0000133041.27682.A2

Jono, 2000, Phosphate regulation of vascular smooth muscle cell calcification, Circ Res, 87, E10, 10.1161/01.RES.87.7.e10

Negri, 2009, FGF 23 in chronic kidney disease and kidney post-transplant patients, Nefrología, 29, 196

Shigematsu, 2004, Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency, Am J Kidney Dis, 44, 250, 10.1053/j.ajkd.2004.04.029

Gutierrez, 2005, Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease, J Am Soc Nephrol, 16, 2205, 10.1681/ASN.2005010052

Jean, 2009, High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients, Nephrol Dial Transplant, 24, 2792, 10.1093/ndt/gfp191

Gutierrez, 2008, Fibroblast Growth Factor 23 and mortality among hemodialysis patients, N Engl J Med, 359, 584, 10.1056/NEJMoa0706130

Gutierrez, 2009, Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease, Circulation, 119, 2545, 10.1161/CIRCULATIONAHA.108.844506

Ketteler, 2003, Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A cross-sectional study, Lancet, 361, 827, 10.1016/S0140-6736(03)12710-9

Mehrotra, 2005, Serum fetuin-A in nondialyzed patients with diabetic nephropathy: Relationship with coronary artery calcification, Kidney Int, 67, 1070, 10.1111/j.1523-1755.2005.00172.x

Mancia, 2007, Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology: 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), J Hypertens, 25, 1105, 10.1097/HJH.0b013e3281fc975a

Gensini, 1983, A more meaningful scoring system for determining the severity of coronary heart disease, Am J Cardiol, 51, 606, 10.1016/S0002-9149(83)80105-2

Neaton, 1992, Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group, Arch Intern Med, 152, 56, 10.1001/archinte.1992.00400130082009

Fliser, 2007, Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The Mild to Moderate Kidney Disease (MMKD) study, J Am Soc Nephrol, 18, 2600, 10.1681/ASN.2006080936

Kanbay, 2009, Phosphate—The silent stealthy cardiorenal culprit in all stages of chronic kidney disease, Blood Purif, 27, 220, 10.1159/000197562

Ketteler, 2005, Fetuin A and extraosseous calcifications in uremia, Curr Opin Nephrol Hypertens, 14, 337, 10.1097/01.mnh.0000172719.26606.6f

Stenvinkel, 2005, Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin, Kidney Int, 67, 2383, 10.1111/j.1523-1755.2005.00345.x

Wang, 2005, Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients, Nephrol Dial Transplant, 20, 1676, 10.1093/ndt/gfh891